Supplemental Vitamins and Minerals for CVD Prevention and Treatment: Systematic Review and Meta-analyses of the Data (Meta-analyses and RCTs) Published Since 2012
试验速览
- 阶段
- 不适用
- 入组人数
- 1
- 主要终点
- CVD mortality
研究概览
简要总结
The use of vitamin and mineral supplementation has historically been to treat and prevent micronutrient deficiencies. In recent years, however, and with their widespread use, the interest has shifted toward a possible role in the prevention and treatment of chronic diseases. The investigators will review and perform meta-analyses of vitamin and mineral supplementation trials in relation to cardiovascular disease. Publications from 2012, both before and including the US Preventive Service Task Force (USPSTF) 2014 review, will be included in the review.
详细描述
Search strategy:
A literature search of the Cochrane Library, Medline and PubMed will be conducted with the following search terms: "dietary supplements or supplement*" AND "cardiovascular disease or myocardial infarction or stroke or cardiovascular death or mortality or all-cause mortality or death." Specific searches will be conducted for individual supplements and included multivitamins, antioxidants, vitamin A, β-carotene, B1, B2, B3 (niacin), B6, B10 (folic acid), B-complex, C, D and E, calcium, iron, zinc, magnesium and selenium. The search will be limited to meta-analyses and RCTs.
Analysis:
Full article review and data extraction will be conducted by two independent investigators, with all disparities reconciled through consensus. The extracted data will include number of cases and total participants/population for the intervention and control group.
Data will be analyzed using Review Manager (RevMan) version 5.3 (The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark) and publication bias will be conducted using STATA software, version 13.0 (College Station, TX, USA). Heterogeneity will be assessed using the Cochran Q statistic at p<0.1 and quantified by the I² statistic. Publication bias will be investigated by visual inspection of funnel plots and quantitative assessment using Begg's and Egger's tests where p<0.05 is considered evidence of small study effects. If <10 trials are available in a meta-analysis, publication bias analysis will not be assessed due to insufficient power.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •English studies
- •Supplements taken orally for at least 6 months
排除标准
- •Studies in children
- •Studies in women who are pregnant or breastfeeding
- •Studies of adults who have serious chronic disease infections such as HIV
- •Studies with combined interventions and no adequate control group (i.e. interventions other than the supplement must be provided to the control group as well)
结局指标
主要结局
CVD mortality
时间窗: 1 year
CHD mortality
时间窗: 1 year
MI mortality
时间窗: 1 year
stroke mortality
时间窗: 1 year
All-cause mortality
时间窗: 1 year
Cardiovascular disease (CVD)
时间窗: 1 year
Coronary heart disease (CHD)
时间窗: 1 year
Myocardial infarction (MI)
时间窗: 1 year
Stroke
时间窗: 1 year
次要结局
未报告次要终点
研究者
David Jenkins
Professor
University of Toronto
